197632-77-2
197632-77-2
Chemical Structure
Fmoc-N-Me-Ser(tBu)-OH
- CAS No.: 197632-77-2
- Formula:C23H27NO5
- Molecular Weight:397.47
IUPAC Name: Fmoc-N-Me-Ser(tBu)-OH
InChIKey: PQSAXALAXPNFMG-FQEVSTJZSA-N
SMILES: O=C(O)[C@H](COC(C)(C)C)N(C(OCC1C2=CC=CC=C2C3=CC=CC=C13)=O)C
Biological Activity: Fmoc-N-Me-Ser(tBu)-OH is a serine derivative[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fmoc-N-Me-Ser(tBu)-OH | 99.84% | Fmoc-N-Me-Ser(tBu)-OH is a serine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Ser(tBu)-OH | 99.97% | Fmoc-Ser(tBu)-OH is a serine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Ser(tBu)-OH-13C3,15N | 99.5% | Fmoc-Ser(tBu)-OH-13C3,15N is a 15N-labeled and 13C-labled Fmoc-Ser(tBu)-OH (HY-W007941). Fmoc-Ser(tBu)-OH is a serine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-Ser(tBu)-OH-15N | Fmoc-Ser(tBu)-OH-15N is the 15N labeled Fmoc-Ser(tBu)-OH. Fmoc-Ser(tBu)-OH is a serine derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-D-Ser(tBu)-OH (Standard) | ≥98% | Fmoc-D-Ser(tBu)-OH (Standard) is the analytical standard of Fmoc-D-Ser(tBu)-OH. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-N-Me-Glu(OtBu)-OH | 99.59% | Fmoc-N-Me-Glu(OtBu)-OH is a glutamic acid derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-N-Me-Leu-OH | 99.72% | Fmoc-N-Me-Leu-OH is an N-Fmoc-N-methyl amino acid that can be used in peptide coupling reactions. Fmoc-N-Me-Leu-OH is primarily used as a standard building block in solid-phase peptide synthesis (SPPS) to introduce N-methylleucine residues into peptide chains, thereby enhancing the enzymatic stability, altering conformational flexibility, and modifying the biological activity of the target peptide. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-D-leucine | 99.49% | N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-D-leucine is a leucine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-N-Me-Asp(OtBu)-OH | 99.64% | Fmoc-N-Me-Asp(OtBu)-OH is an aspartic acid derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fmoc-N-Me-Thr(tBu)-OH | 98.98% | Fmoc-N-Me-Thr(tBu)-OH is a threonine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Fmoc-N,O-dimethyl-L-serine | 97.89% | N-Fmoc-N,O-dimethyl-L-serine is a serine derivative that can be used for coibamide A synthesis. Coibamide A is a marine natural product with potent antiproliferative activity against human cancer cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
